Literature DB >> 8642629

Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?

E W Baxter1, K Blyth, L A Donehower, E R Cameron, D E Onions, J C Neil.   

Abstract

The effect of Moloney murine leukemia virus (MoMLV) infection was examined in mice lacking a functional p53 gene. Virus-infected p53-/- mice developed tumors significantly faster than uninfected p53-/- or virus-infected p53+/+ littermates. However, the degree of synergy between MoMLV and the p53 null genotype was weaker than the synergy between either of these and c-myc transgenes. A similar range of T-cell tumor phenotypes was represented in all p53 genotype groups, including p53-/- mice, which developed thymic lymphomas as the most common of several neoplastic diseases. Lack of p53 was associated with higher rates of metastasis and the ready establishment of tumors in tissue culture. Loss of the wild-type allele was a common feature of tumors in p53+/- mice and was complete in tumor cells in vitro, but this appeared to occur by a mechanism other than proviral insertion at the wild-type allele. A lower average MoMLV proviral copy number was observed in tumors of the p53 null and heterozygote groups, suggesting that the absence of a functional p53 gene reduced the number of steps required to complete the malignant phenotype. Mink cell focus-forming virus-like proviruses were detected in tumors of all infected mice but were relatively rare in p53 null mice. Analysis of c-myc, pim-1, and pal-1 showed that these loci were occupied by proviruses in some cases but at similar frequencies in p53 wild-type and null mice. In conclusion, while inactivation of p53 in the germ line predisposes mice to tumors similar in phenotype to those induced by MoMLV, it appears that virus-induced tumors generally occur without p53 loss. We speculate that a bcl-2-like function carried or induced by MoMLV may underlie this p53-independent pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642629      PMCID: PMC190045     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

2.  Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells.

Authors:  A Rein
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

3.  Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias.

Authors:  J C Neil; D Hughes; R McFarlane; N M Wilkie; D E Onions; G Lees; O Jarrett
Journal:  Nature       Date:  1984 Apr 26-May 2       Impact factor: 49.962

4.  M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors.

Authors:  H van der Putten; W Quint; J van Raaij; E R Maandag; I M Verma; A Berns
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

5.  Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.

Authors:  K Blyth; A Terry; M O'Hara; E W Baxter; M Campbell; M Stewart; L A Donehower; D E Onions; J C Neil; E R Cameron
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

6.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

7.  Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas.

Authors:  J C Renauld; A Vink; J Louahed; J Van Snick
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

8.  The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.

Authors:  A Elson; C Deng; J Campos-Torres; L A Donehower; P Leder
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

9.  5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains.

Authors:  K B Marcu; J Banerji; N A Penncavage; R Lang; N Arnheim
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

10.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.

Authors:  O Bernard; S Cory; S Gerondakis; E Webb; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  11 in total

1.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.

Authors:  X Zou; F Cong; M Coutts; G Cattoretti; S P Goff; K Calame
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.

Authors:  Erica Marchlik; Richard Kalman; Naomi Rosenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.

Authors:  E W Baxter; K Blyth; E R Cameron; J C Neil
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene.

Authors:  M Stewart; A Terry; M Hu; M O'Hara; K Blyth; E Baxter; E Cameron; D E Onions; J C Neil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Loss of heterozygosity at the Ink4a/Arf locus facilitates Abelson virus transformation of pre-B cells.

Authors:  J Mostecki; A Halgren; A Radfar; Z Sachs; J Ravitz; K C Thome; N Rosenberg
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells.

Authors:  I Unnikrishnan; A Radfar; J Jenab-Wolcott; N Rosenberg
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

9.  Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.

Authors:  Camille A Huser; Kathryn L Gilroy; Jeroen de Ridder; Anna Kilbey; Gillian Borland; Nancy Mackay; Alma Jenkins; Margaret Bell; Pawel Herzyk; Louise van der Weyden; David J Adams; Alistair G Rust; Ewan Cameron; James C Neil
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

10.  Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas.

Authors:  Monica Stewart; Nancy Mackay; Linda Hanlon; Karen Blyth; Linda Scobie; Ewan Cameron; James C Neil
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.